ARTICLE | Company News
Galen, Gilead sales and marketing update
March 5, 2012 8:00 AM UTC
Galen's Galen US Inc. subsidiary acquired exclusive, worldwide rights to Gilead's DaunoXome. The liposomal formulation of daunorubicin is approved in the U.S. to treat AIDS/HIV-associated Kaposi's sa...